Diabetes and respiratory diseases as comorbid conditions in COVID-19 patients from Kazakhstan: a retrospective pilot study.

ABSTRACT:

Background

Diabetes and respiratory diseases are prevalent in Central Asia, and their prevention represents an opportunity to increase life expectancy in the region, especially in Kazakhstan. This study aims to analyze trends in the prevalence of diabetes and respiratory diseases as comorbidities in patients with recent COVID-19 infections, based on the information obtained from several clinics in Almaty, Kazakhstan.

Methods

This study was conducted as a cross-sectional analysis using de-identified electronic medical records from a multidisciplinary hospital in Almaty, Kazakhstan. Adults hospitalized with laboratory-confirmed COVID-19 during 2021-2022 were included (N = 292; mean age 55 years, range 18-91). Continuous variables were summarized with means and standard

SUBMITTER: Tazhibayeva K 

PROVIDER: S-EPMC12716145 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature